Adcock Ingram Holdings Ltd (AIPJ.J)

AIPJ.J on Johannesburg Stock Exchange

5,205.00ZAc
8:52am EDT
Price Change (% chg)

306.00c (+6.25%)
Prev Close
4,899.00c
Open
4,935.00c
Day's High
5,263.00c
Day's Low
4,935.00c
Volume
3,046,082
Avg. Vol
581,488
52-wk High
7,250.00c
52-wk Low
4,616.00c

AIPJ.J

Chart for AIPJ.J

About

Adcock Ingram Holdings Ltd is a manufacturer, marketer and distributor of healthcare products. The Company is a supplier of hospital and critical care products. Its product portfolio includes branded and generic prescription medicines, over the counter (OTC)/fast moving consumer goods (FMCG) brands, intravenous solutions, blood... (more)

Overall

Beta: 0.57
Market Cap (Mil.): R8,604.84
Shares Outstanding (Mil.): 175.64
Dividend: --
Yield (%): --

Financials

  AIPJ.J Industry Sector
P/E (TTM): 36.11 18.55 34.43
EPS (TTM): 1.36 -- --
ROI: 5.52 9.54 50.48
ROE: 6.29 10.97 58.91
Search Stocks

UPDATE 1-S.Africa's Bidvest mulls raising Adcock stake to majority

* Bidvest intends to lift holding to over 50 pct -document

21 Aug 2014

BRIEF-Adcock sees 9-month headline loss range per share of 175 to 185 cents

* Group recorded an extremely weak trading performance for nine-month period ended 30 June 2014

18 Aug 2014

BRIEF-Adcock Ingram expects to report headline loss per share for 9 months to end June

* Board of directors of adcock ingram ("board") has concluded with absolute certainty that financial results for nine-month period ended 30 june 2014 will result in a basic and headline loss per share,

05 Aug 2014

UPDATE 1-New Adcock boss to overhaul structure of loss-making drugmaker

* Shares fall more than 2 pct (Adds CEO comment, shares)

27 May 2014

South Africa's Adcock swings to first-half loss, halts dividend

JOHANNESBURG, May 27 - South Africa's second-biggest drugmaker Adcock Ingram posted close to a $4 million first-half loss on Tuesday, hit by rising raw materials prices and costs related to a failed $1.2 billion takeover bid from a Chilean suitor.

27 May 2014

BRIEF-Adcock Ingram Holdings H1 gross profit drops 14 pct

* Gross profit for six-month period decreased by 13,9% to r846 million (2013: r983 million)

27 May 2014

South Africa's Adcock flags H1 loss, shares fall

JOHANNESBURG, May 20 - South Africa's No.2 drugmaker, Adcock Ingram Holdings Ltd, flagged a first-half loss on Tuesday, citing costs related to a failed $1.2 billion takeover bid from Chile's CFR Pharmaceuticals .

20 May 2014

BRIEF-Adcock expects H1 headline loss per share of between 22-24 cents

* Shareholders are advised that company is expecting to report a loss per share for interim financial period ended 31 March 2014 of between 24 cents and 25 cents, compared to EPS of 188.0 cents reported for previous comparable six-month period

20 May 2014

UPDATE 1-South Africa's Adcock names industry newcomer as CEO

* New CEO inherits an underperforming company (Adds analyst comment, shares background)

03 Apr 2014

BRIEF-Adcock names Kevin Wakeford as CEO

* Kevin Wakeford has been appointed as chief executive officer of Adcock Ingram with immediate effect Source text for Eikon: Further company coverage:

03 Apr 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$250.00
Provider: MarketLine (a Datamonitor Company)
$50.00
Provider: Directors Deals Ltd.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks